UBS Group’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Other funds holding WST
UBS Group's WST Position: Q3 2026 in Review
UBS Group reduced its West Pharmaceutical (WST) stake by 38% in Q3 2026, selling an estimated $50.4M and leaving 231,667 shares worth $85.9M. The position accounts for 0.01% of the portfolio, ranked #1215.
UBS Group first reported a position in WST in Q4 2014 and has held it in 48 quarters since. The position peaked at $134M in Q2 2026. 877 funds tracked by Wall St. Rank hold WST as of Q3 2026.
- UBS Group held 231,667 shares of West Pharmaceutical worth $85.9M as of Q3 2026.
- UBS Group sold 142,694 West Pharmaceutical shares in Q3 2026, an estimated $50.4M.
- West Pharmaceutical made up 0.01% of UBS Group's portfolio in Q3 2026, its #1215 holding.
- UBS Group first reported a position in West Pharmaceutical in Q4 2014 and has held it in 48 quarters since.
- UBS Group's West Pharmaceutical position peaked at $134M in Q2 2026.
- 877 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.
Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.